Coldstream and Goodwin Biotechnology will co-exhibit at the World ADC Summit in San Francisco, CA, from October 14th to 17th. Please meet us at Booth #13 to discuss your cytotoxic antibody drug conjugation needs.
Goodwin and Coldstream provide a Single Source SolutionTM for the development and manufacturing of cytotoxic ADCs and other bioconjugates. Our partnership effectively consolidates the supply chain for the manufacturing of ADC drug substances and drug products for exploratory proof-of-concept studies and preclinical/tox studies through early-stage/late-stage clinical trials and commercial supply.
For more information or to schedule a meeting, please visit our web site at:http://www.coldstreamlabs.com/antibody-drug-conjugates.